Filing Details
- Accession Number:
- 0001209191-18-046335
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-13 08:34:39
- Reporting Period:
- 2018-08-09
- Accepted Time:
- 2018-08-13 08:34:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
818686 | Teva Pharmaceutical Industries Ltd | TEVA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1721514 | Beck Iris Codner | C/O Teva Pharmaceutical Industries Ltd. 5 Basel Street Petach Tikva L3 4951033 | Evp Global Brand&Communication | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2018-08-09 | 4,165 | $22.70 | 8,290 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The Ordinary Shares were sold in New Israeli Shekels. The price shown is calculated based on the exchange rate of NIS 3.683 per $1.00, as published by the Bank of Israel on August 9, 2018.